Floatz logo

MERCAPTOPURINE ANHYDROUS

Acute Lymphoblastic Leukemia

Dana-Farber Cancer InstituteSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
75/ 100
Competitive Position
65/ 100

Competitive context

246 Active assets in the Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
Gm-Csf
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Peripheral Blood Stem Cells, Allogeneic, Cd34 Positive
Fred Hutchinson Cancer Center
Phase 2/3BBB
THIOGUANINE ANHYDROUS
St. Jude Children's Research Hospital
Phase 4BBB
Equine Atg
Instituto Nacional de Cancer, Brazil
Phase 3BBB
Asparaginase
Centre Hospitalier Universitaire de Nice
Phase 4BB

View all 50 →

Same molecule, other indications

MERCAPTOPURINE ANHYDROUS is also rated in:

adult acute lymphoblastic leukemiaActive
A
Indicative · Phase 4
81 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative · Phase 3
80 / 100
View asset →
childhood acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 3
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →